Doxorubicin-batch-01-hnmr-abmole 奥默生物
Xeomin （incobotulinumtoxinA） 说明书
Xeomin® (incobotulinumtoxinA)Document Number: IC-0241 Last Review Date: 03/29/2016Date of Origin: 06/21/2011Dates Reviewed:09/2011, 12/2011, 03/2012, 06/2012, 09/2012, 12/2012, 02/2013, 03/2013, 06/2013,09/2013, 12/2013, 03/2014, 03/2015, 6/2015, 9/2015, 12/2015, 03/2016I.Length of AuthorizationCoverage is provided for six months and may be renewed.II.Dosing LimitsA.Quantity Limit (max daily dose) [Pharmacy Benefit]:−N/AB.Max Units (per dose and over time) [Medical Benefit]:Xeomin (J0588)Male: 400 billable units per 12 weeks (84 days)Female: 400 billable units per 12 weeks (84 days)III.Initial Approval CriteriaCoverage is provided in the following conditions:Xeomin is considered medically necessary in the following:•Patient age 18 or greater; AND•Cervical dystonia †•Patient has sustained head tilt; OR•Abdominal posturing with limited range of motion in neck; AND•History of recurrent involuntary contraction of one or more muscles in the neckBlepharospasms †Upper limb spasticity ††FDA Approved Indication(s)IV.Renewal CriteriaCoverage can be renewed based upon the following criteria:•Patient continues to meet criteria identified in section III; AND•Disease response; AND•Absence of unacceptable toxicity from the drugV.Dosage/AdministrationCervical Dystonia 120 units divided among the affected muscles every 12 weeks orlonger, as necessaryBlepharospasm 1.25 – 5.6 units per injection site, not to exceed 35 units per eye, every12 weeks or longer, as necessaryUpper limb spasticity Up to 400 units total no sooner than every 12 weeksVI.Billing Code/Availability InformationJcode:•J0588 – Xeomin (Merz GmbH) 50 units, 100 units Injection: 1 billable unit = 1 unitNDC:N/AVII.References1.Xeomin [package insert]. Dessau-Rosslau, Germany; Merz Group Services GmbH;December 2015. Accessed January 2015.2.Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, KarpB, Ludlow CL, Miyasaki JM, Naumann M, So Y, Therapeutics and Technology AssessmentSubcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxinfor the treatment of movement disorders (an evidence-based review): report of theTherapeutics and Technology Assessment Subcommittee of the American Academy ofNeurology. Neurology 2008 May 6;70(19):1699-706.3.Cahaba Government Benefit Administrators, LLC. Local Coverage Determination (LCD):Botulinum Toxins (L34253). Centers for Medicare & Medicaid Services, Inc. Updated on12/16/2015 with effective date 10/1/2015. Accessed January 2016.4.CGS, Administrators, LLC. Local Coverage Determination (LCD): Botulinum Toxins(L33949). Centers for Medicare & Medicaid Services, Inc. Updated on 11/23/2015 witheffective date 10/1/2015. Accessed January 2016.5.First Coast Service Options, Inc. Local Coverage Determination (LCD): Botulinum Toxins(L33274). Centers for Medicare & Medicaid Services, Inc. Updated on 07/01/2014 witheffective date 10/1/2015. Accessed January 2016.6.National Government Services, Inc. Local Coverage Determination (LCD): BotulinumToxins (L33646). Centers for Medicare & Medicaid Services, Inc. Updated on 10/30/2015 with effective date 10/1/2015. Accessed January 2016.7.Noridian Administrative Services, LLC. Local Coverage Determination (LCD): BotulinumToxin Types A and B (L35172). Centers for Medicare & Medicaid Services, Inc. Updated on 11/20/2015 with effective date 10/1/2015. Accessed January 2016.8.Noridian Healthcare Solutions, LLC. Local Coverage Determination (LCD): BotulinumToxin Types A and B (L35170). Centers for Medicare & Medicaid Services, Inc. Updated on 11/20/2015 with effective date 10/1/2015. Accessed January 2016.9.Palmetto GBA. Local Coverage Determination (LCD): Chemodenervation (L33458).Centers for Medicare & Medicaid Services, Inc. Updated on 11/20/2015 with effective date 12/16/2015. Accessed January 2016.10.Wisconsin Physicians Service Insurance Corporation. Local Coverage Determination(LCD): Botulinum Toxin Type A & Type B (L34635). Centers for Medicare & MedicaidServices, Inc. Updated on 11/16/2015 with effective date 12/1/2015. Accessed January2016.Appendix 1 – Covered Diagnosis Codes333.81 Blepharospasm333.83 Spasmodic torticollis342.10 Spastic hemiplegia and hemiparesis affecting unspecified side342.11 Spastic hemiplegia and hemiparesis affecting dominant side342.12 Spastic hemiplegia and hemiparesis affecting nondominant side343.0 Diplegic; Congenital diplegia; Congenital paraplegia343.1 Hemiplegic; Congenital hemiplegia343.2 Quadriplegic; Tetraplegic344.03 Quadriplegia, C5-C7, complete344.04 Quadriplegia, C5-C7, incomplete344.2 Diplegia of upper limbs344.40 Monoplegia of upper limb affecting unspecified side344.41 Monoplegia of upper limb affecting dominant side344.42 Monoplegia of upper limb affecting nondominant side438.20 Late effects of cerebrovascular disease, hemiplegia affecting unspecified side438.21 Late effects of cerebrovascular disease, hemiplegia affecting dominant side438.22 Late effects of cerebrovascular disease, hemiplegia affecting non-dominant side438.30 Late effects of cerebrovascular disease; monoplegia of upper limb affecting unspecified side 438.31 Late effects of cerebrovascular disease; monoplegia of upper limb affecting dominant side 438.32 Late effects of cerebrovascular disease; monoplegia of upper limb affecting nondominantside723.5 Torticollis, unspecifiedG24.3 Spasmodic torticollisG24.5 BlepharospasmG80.1 Spastic diplegic cerebral palsyG80.2 Spastic hemiplegic cerebral palsyG80.3 Spastic quadriplegic cerebral palsyG81.10 Spastic hemiplegia affecting unspecified sideG81.11 Spastic hemiplegia affecting right dominant sideG81.12 Spastic hemiplegia affecting left dominant sideG81.13 Spastic hemiplegia affecting right nondominant sideG81.14 Spastic hemiplegia affecting left nondominant sideG82.53 Quadriplegia, C5-C7, completeG82.54 Quadriplegia, C5-C7, incompleteG83.0 Diplegia of upper limbs, Diplegia (Upper), Paralysis of both upper limbs G83.20 Monoplegia of upper limb affecting unspecified sideG83.21 Monoplegia of upper limb affecting right dominant sideG83.22 Monoplegia of upper limb affecting left dominant sideG83.23 Monoplegia of upper limb affecting right nondominant sideG83.24 Monoplegia of upper limb affecting left nondominant sideI69.031 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant sideI69.032 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant sideI69.033 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant sideI69.034 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant sideI69.039 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified sideI69.051 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant sideI69.052 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant sideI69.053 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant sideI69.054 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant sideI69.059 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified sideI69.131 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant sideI69.132 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant sideI69.133 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant sideI69.134 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant sideI69.139 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified siteI69.151 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant sideI69.152 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant sideI69.153 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant sideI69.154 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant sideI69.159 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified sideI69.231 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant sideI69.232 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant sideI69.233 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant sideI69.234 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant sideI69.239 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified siteI69.251 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhageaffecting right dominant sideI69.252 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant sideI69.253 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant sideI69.254 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant sideI69.259 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified sideI69.331 Monoplegia of upper limb following cerebral infarction affecting right dominant sideI69.332 Monoplegia of upper limb following cerebral infarction affecting left dominant sideI69.333 Monoplegia of upper limb following cerebral infarction affecting right non-dominant side I69.334 Monoplegia of upper limb following cerebral infarction affecting left non-dominant side I69.339 Monoplegia of upper limb following cerebral infarction affecting unspecified siteI69.351 Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side I69.352 Hemiplegia and hemiparesis following cerebral infarction affecting left dominant sideI69.353 Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant sideI69.354 Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant sideI69.359 Hemiplegia and hemiparesis following cerebral infarction affecting unspecified sideI69.831 Monoplegia of upper limb following other cerebrovascular disease affecting right dominant sideI69.832 Monoplegia of upper limb following other cerebrovascular disease affecting left dominant sideI69.833 Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant sideI69.834 Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant sideI69.839 Monoplegia of upper limb following other cerebrovascular disease affecting unspecified siteI69.851 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant sideI69.852 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant sideI69.853 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant sideI69.854 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant sideI69.859 Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified sideI69.931 Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant sideI69.932 Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant sideI69.933 Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant sideI69.934 Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant sideI69.939 Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified sideI69.951 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant sideI69.952 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant sideI69.953 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant sideI69.954 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant sideI69.959 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified sideM43.6 TorticollisAppendix 2 – Centers for Medicare and Medicaid Services (CMS)Medicare coverage for outpatient (Part B) drugs is outlined in the Medicare Benefit Policy Manual (Pub. 100-2), Chapter 15, §50 Drugs and Biologicals. In addition, National Coverage Determination (NCD) and Local Coverage Determinations (LCDs) may exist and compliance with these policies is required where applicable. They can be found at: /medicare-coverage-database/search/advanced-search.aspx. Additional indications may be covered at the discretion of the health plan.Medicare Part B Covered Diagnosis Codes (applicable to existing NCD/LCD):Jurisdiction(s): 10 (J) NCD/LCD Document (s): L34253https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=34253&ver=12&Date=02%2f01%2f2016&DocID=L34253&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): 15 NCD/LCD Document (s): L33949https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=33949&ver=7&Date=02%2f01%2f2016&DocID=L33949&SearchType=Advan ced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): 9 (N) NCD/LCD Document (s): L33274https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=33274&ver=3&Date=02%2f01%2f2016&DocID=L33274&SearchType=Advan ced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): 11 (M) NCD/LCD Document (s): L33458https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=33458&ver=20&Date=02%2f01%2f2016&DocID=L33458&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): 6,K NCD/LCD Document (s): L33646https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=33646&ver=11&Date=02%2f01%2f2016&DocID=L33646&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): F NCD/LCD Document (s): L35172https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=35172&ver=19&Date=02%2f01%2f2016&DocID=L35172&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): (J-E) NCD/LCD Document (s): L35170https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=35170&ver=11&Date=02%2f01%2f2016&DocID=L35170&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction(s): 5, 8 NCD/LCD Document (s): L34635https:///medicare-coverage-database/details/lcd-details.aspx?LCDId=34635&ver=12&Date=02%2f01%2f2016&DocID=L34635&SearchType=Adva nced&bc=KAAAAAgAAAAAAA%3d%3d&Jurisdiction Applicable State/US Territory ContractorE CA,HI, NV, AS, GU, CNMI Noridian Administrative Services (NAS)F AK, WA, OR, ID, ND, SD, MT, WY,Noridian Administrative Services (NAS) UT, AZ5 KS, NE, IA, MO Wisconsin Physicians Service (WPS)6 MN, WI, IL National Government Services (NGS)H LA, AR, MS, TX, OK, CO, NM Novitas Solutions8 MI, IN Wisconsin Physicians Service (WPS)9 (N) FL, PR, VI First Coast Service Options10 (J) TN, GA, AL Cahaba Government Benefit Administrators11 (M) NC, SC, VA, WV Palmetto GBA12 (L) DE, MD, PA, NJ, DC Novitas SolutionsK NY, CT, MA, RI, VT, ME, NH National Government Services (NGS)15 KY, OH CGS Administrators, LLC。
分子生物学词汇(中英文对照表 )
第一页A band|A带A chromosome|A染色体[二倍体染色体组中的正常染色体（不同于B染色体）] A site|[核糖体]A部位ABA|脱落酸abasic site|脱碱基位点，无碱基位点abaxial|远轴的abequose|阿比可糖，beta脱氧岩藻糖aberrant splicing|异常剪接aberration|象差；畸变；失常abiogenesis|自然发生论，无生源论ablastin|抑殖素（抑制微生物细胞分裂或生殖的一种抗体）abnormal distrbution|非正态分布abnormality|异常，失常；畸形，畸变ABO blood group system|ABO血型系统aboriginal mouse|原生鼠abortin|流产素abortion|流产，败育abortive egg|败育卵abortive infection|流产（性）感染abortive transduction|流产（性）转导ABP|肌动蛋白结合蛋白abrin|相思豆毒蛋白abscisic acid|脱落酸abscission|脱落absolute|绝对的absolute configuration|绝对构型absolute counting|绝对测量absolute deviation|绝对偏差absolute error|绝对误差absorbance|吸收，吸光度absorbed dose|吸收剂量absorbent|吸收剂absorptiometer|吸光计absorptiometry|吸光测定法absorption|吸收absorption band|吸收谱带absorption cell|吸收池absorption coefficient|吸收系数absorption spectroscopy|吸收光谱法absorption spectrum|吸收光谱；吸收谱absorptive endocytosis|吸收（型）胞吞（作用） absorptive pinocytosis|吸收（型）胞饮（作用） absorptivity|吸光系数；吸收性abundance|丰度abundant|丰富的，高丰度的abundant mRNAs|高丰度mRNAabzyme|抗体酶acaricidin|杀螨剂accedent variation|偶然变异accelerated flow method|加速流动法accepting arm|[tRNA的]接纳臂acceptor|接纳体，（接）受体acceptor site|接纳位点，接受位点acceptor splicing site|剪接受体acceptor stem|[tRNA的]接纳茎accessible|可及的accessible promoter|可及启动子accessible surface|可及表面accessory|零件，附件；辅助的accessory cell|佐细胞accessory chromosome|副染色体accessory factor|辅助因子accessory nucleus|副核accessory pigment|辅助色素accessory protein|辅助蛋白（质）accommodation|顺应accumulation|积累，累积accuracy|准确度acenaphthene|二氢苊acene|并苯acentric|无着丝粒的acentric fragment|无着丝粒断片acentric ring|无着丝粒环acetal|缩醛acetaldehyde|乙醛acetalresin|缩醛树脂acetamidase|乙酰胺酶acetamide|乙酰胺acetate|乙酸盐acetic acid|乙酸，醋酸acetic acid bacteria|乙酸菌，醋酸菌acetic anhydride|乙酸酐acetification|乙酸化作用，醋化作用acetin|乙酸甘油酯，三乙酰甘油酯acetoacetic acid|乙酰乙酸Acetobacter|醋杆菌属acetogen|产乙酸菌acetogenic bacteria|产乙酸菌acetome body|酮体acetome powder|丙酮制粉[在-30度以下加丙酮制成的蛋白质匀浆物] acetomitrile|乙腈acetone|丙酮acetyl|乙酰基acetyl coenzyme A|乙酰辅酶Aacetylcholine|乙酰胆碱acetylcholine agonist|乙酰胆碱拮抗剂acetylcholine receptor|乙酰胆碱受体acetylcholinesterase|乙酰胆碱酯酶acetylene|乙炔acetylene reduction test|乙炔还原试验[检查生物体的固氮能力] acetylglucosaminidase|乙酰葡糖胺糖苷酶acetylglutamate synthetase|乙酰谷氨酸合成酶acetylsalicylate|乙酰水杨酸；乙酰水杨酸盐、酯、根acetylsalicylic acid|乙酰水杨酸acetylspiramycin|乙酰螺旋霉素AchE|乙酰胆碱酯酶achiral|非手性的acholeplasma|无胆甾原体AchR|乙酰胆碱受体achromatic|消色的；消色差的achromatic color|无色achromatic lens|消色差透镜achromatin|非染色质acid catalysis|酸催化acid fibroblast growth factor|酸性成纤维细胞生长因子acid fuchsin|酸性品红acid glycoprotein|酸性糖蛋白acid hydrolyzed casein|酸水解酪蛋白acid medium|酸性培养基acid mucopolysaccharide|酸性粘多糖acid phosphatase|酸性磷酸酶acid protease|酸性蛋白酶acid solvent|酸性溶剂acidic|酸性的acidic amino acid|酸性氨基酸acidic protein|酸性蛋白质[有时特指非组蛋白]acidic transactivator|酸性反式激活蛋白acidic transcription activator|酸性转录激活蛋白 acidification|酸化（作用）acidifying|酸化（作用）acidolysis|酸解acidophilia|嗜酸性acidophilic bacteria|嗜酸菌acidophilous milk|酸奶aclacinomycin|阿克拉霉素acoelomata|无体腔动物acomitic acid|乌头酸aconitase|顺乌头酸酶aconitate|乌头酸；乌头酸盐、酯、根aconitine|乌头碱aconitum alkaloid|乌头属生物碱ACP|酰基载体蛋白acquired character|获得性状acquired immunity|获得性免疫acridine|吖啶acridine alkaloid|吖啶（类）生物碱acridine dye|吖啶燃料acridine orange|吖啶橙acridine yellow|吖啶黄acriflavine|吖啶黄素acroblast|原顶体acrocentric chromosome|近端着丝染色体acrolein|丙烯醛acrolein polymer|丙烯醛类聚合物acrolein resin|丙烯醛树脂acropetal translocation|向顶运输acrosin|顶体蛋白acrosomal protease|顶体蛋白酶acrosomal reaction|顶体反应acrosome|顶体acrosome reaction|顶体反应acrosomic granule|原顶体acrosyndesis|端部联会acrylamide|丙烯酰胺acrylate|丙烯酸酯、盐acrylic acid|丙烯酸acrylic polymer|丙烯酸（酯）类聚合物acrylic resin|丙烯酸（酯）类树脂acrylketone|丙烯酮acrylonitrile|丙烯腈actidione|放线（菌）酮[即环己酰亚胺]actin|肌动蛋白actin filament|肌动蛋白丝actinin|辅肌动蛋白[分为alfa、beta两种，beta蛋白即加帽蛋白] actinmicrofilament|肌动蛋白微丝actinometer|化学光度计actinomorphy|辐射对称[用于描述植物的花]actinomycetes|放线菌actinomycin D|放线菌素Dactinospectacin|放线壮观素，壮观霉素，奇霉素action|作用action current|动作电流action potential|动作电位action spectrum|动作光谱activated sludge|活性污泥activated support|活化支持体activating group|活化基团activating transcription factor|转录激活因子activation|激活；活化activation analysis|活化分析activation energy|活化能activator|激活物，激活剂，激活蛋白activator protein|激活蛋白active absorption|主动吸收active biomass|活生物质active carbon|活性碳active center|活性中心active chromatin|活性染色质active dry yeast|活性干酵母active dydrogen compounds|活性氢化合物active ester of amino acid|氨基酸的活化酯active hydrogen|活性氢active immunity|主动免疫active oxygen|活性氧active site|活性部位，活性中心active transport|主动转运active uptake|主动吸收activin|活化素[由垂体合成并由睾丸和卵巢分泌的性激素]activity|活性，活度，（放射性）活度actomyosin|肌动球蛋白actophorin|载肌动蛋白[一种肌动蛋白结合蛋白]acute|急性的acute infection|急性感染acute phase|急性期acute phase protein|急性期蛋白，急相蛋白acute phase reaction|急性期反应，急相反应[炎症反应急性期机体的防御反应] acute phase reactive protein|急性期反应蛋白，急相反应蛋白acute phase response|急性期反应，急相反应acute toxicity|急性毒性ACV|无环鸟苷acyclic nucleotide|无环核苷酸acycloguanosine|无环鸟苷，9-（2-羟乙氧甲基）鸟嘌呤acyclovir|无环鸟苷acyl|酰基acyl carrier protein|酰基载体蛋白acyl cation|酰（基）正离子acyl chloride|酰氯acyl CoA|脂酰辅酶Aacyl coenzyem A|脂酰辅酶Aacyl fluoride|酰氟acyl halide|酰卤acylamino acid|酰基氨基酸acylase|酰基转移酶acylating agent|酰化剂acylation|酰化acylazide|酰叠氮acylbromide|酰溴acyloin|偶姻acyltransferase|酰基转移酶adamantanamine|金刚烷胺[曾用作抗病毒剂]adamantane|金刚烷adaptability|适应性adaptation|适应adapter|衔接头；衔接子adapter protein|衔接蛋白质adaptin|衔接蛋白[衔接网格蛋白与其他蛋白的胞质区]adaptive behavior|适应性行为adaptive enzyme|适应酶adaptive molecule|衔接分子adaptive response|适应反应[大肠杆菌中的DNA修复系统]adaptor|衔接头；衔接子adaxial|近轴的addition|加成addition compound|加成化合物addition haploid|附加单倍体addition line|附加系additive|添加物，添加剂additive effect|加性效应additive genetic variance|加性遗传方差additive recombination|插入重组，加插重组[因DNA插入而引起的基因重组] addressin|地址素[选择蛋白(selectin)的寡糖配体，与淋巴细胞归巢有关]adducin|内收蛋白[一种细胞膜骨架蛋白，可与钙调蛋白结合]adduct|加合物，加成化合物adduct ion|加合离子adenine|腺嘌呤adenine arabinoside|啊糖腺苷adenine phosphoribosyltransferase|腺嘌呤磷酸核糖转移酶adenoma|腺瘤adenosine|腺嘌呤核苷，腺苷adenosine deaminase|腺苷脱氨酶adenosine diphoshate|腺苷二磷酸adenosine monophosphate|腺苷（一磷）酸adenosine phosphosulfate|腺苷酰硫酸adenosine triphosphatase|腺苷三磷酸酶adenosine triphosphate|腺苷三磷酸adenovirus|腺病毒adenylate|腺苷酸；腺苷酸盐、酯、根adenylate cyclase|腺苷酸环化酶adenylate energy charge|腺苷酸能荷adenylate kinase|腺苷酸激酶adenylic acid|腺苷酸adenylyl cyclase|腺苷酸环化酶adenylylation|腺苷酰化adherence|粘着，粘附，粘连；贴壁adherent cell|贴壁赴 徽匙牛ㄐ裕┫赴 掣剑ㄐ裕┫赴?/P>adherent culture|贴壁培养adhering junction|粘着连接adhesin|粘附素[如见于大肠杆菌]adhesion|吸附，结合，粘合；粘着，粘附，粘连adhesion factor|粘着因子，粘附因子adhesion molecule|粘着分子，粘附分子adhesion plaque|粘着斑adhesion protein|粘着蛋白，吸附蛋白adhesion receptor|粘着受体adhesion zone|粘着带[如见于细菌壁膜之间]adhesive|粘合剂，胶粘剂adhesive glycoprotein|粘着糖蛋白adipic acid|己二酸，肥酸adipocyte|脂肪细胞adipokinetic hormone|脂动激素[见于昆虫]adipose tissue|脂肪组织adjust|[动]调节，调整；修正adjustable|可调的adjustable miropipettor|可调微量移液管adjustable spanner|活动扳手adjusted retention time|调整保留时间adjusted retention volume|调整保留体积adjuvant|佐剂adjuvant cytokine|佐剂细胞因子adjuvant peptide|佐剂肽adjuvanticity|佐剂（活）性adoptive immunity|过继免疫adoptive transfer|过继转移ADP ribosylation|ADP核糖基化ADP ribosylation factor|ADP核糖基化因子ADP ribosyltransferase|ADP核糖基转移酶adrenal cortical hormone|肾上腺皮质(激)素adrenaline|肾上腺素adrenergic receptor|肾上腺素能受体adrenocepter|肾上腺素受体adrenocorticotropic hormone|促肾上腺皮质(激)素adrenodoxin|肾上腺皮质铁氧还蛋白adriamycin|阿霉素，亚德里亚霉素adsorbent|吸附剂adsorption|吸附adsorption catalysis|吸附催化adsorption center|吸附中心adsorption chromatography|吸附层析adsorption film|吸附膜adsorption isobar|吸附等压线adsorption isotherm|吸附等温线adsorption layer|吸附层adsorption potential|吸附电势adsorption precipitation|吸附沉淀adsorption quantity|吸附量adult diarrhea rotavirus|成人腹泻轮状病毒advanced glycosylation|高级糖基化advanced glycosylation end product|高级糖基化终产物 adventitious|不定的，无定形的adverse effect|反效果，副作用aecidiospore|锈孢子，春孢子aeciospore|锈孢子，春孢子aequorin|水母蛋白，水母素aeration|通气aerator|加气仪，加气装置aerial mycelium|气生菌丝体aerobe|需氧菌[利用分子氧进行呼吸产能并维持正常生长繁殖的细菌] aerobic|需氧的aerobic bacteria|需氧（细）菌aerobic cultivation|需氧培养aerobic glycolysis|有氧酵解aerobic metabolism|有氧代谢aerobic respiration|需氧呼吸aerobic waste treatment|需氧废物处理aerobiosis|需氧生活aerogel|气凝胶aerogen|产气菌aerolysin|气单胞菌溶素Aeromonas|气单胞菌属aerosol|气溶胶aerosol gene delivery|气溶胶基因送递aerospray ionization|气喷射离子化作用aerotaxis|趋氧性[（细胞）随环境中氧浓度梯度进行定向运动]aerotolerant bacteria|耐氧菌[不受氧毒害的厌氧菌]aerotropism|向氧性aesculin|七叶苷，七叶灵aetiology|病原学B cell|B细胞B cell antigen receptor|B细胞抗原受体B cell differentiation factor|B细胞分化因子B cell growth factor|B细胞生长因子B cell proliferation|B细胞增殖B cell receptor|B细胞受体B cell transformation|B细胞转化B chromosome|B染色体[许多生物（如玉米）所具有的异染质染色体] B to Z transition|B-Z转换[B型DNA向Z型DNA转换]Bacillariophyta|硅藻门Bacillus|芽胞杆菌属Bacillus anthracis|炭疽杆菌属Bacillus subtillis|枯草芽胞杆菌bacitracin|杆菌肽back donation|反馈作用back flushing|反吹，反冲洗back mutation|回复突变[突变基因又突变为原由状态]backbone|主链；骨架backbone hydrogen bond|主链氢键backbone wire model|主链金属丝模型[主要反应主链走向的实体模型]backcross|回交backflushing chromatography|反吹层析，反冲层析background|背景，本底background absorption|背景吸收background absorption correction|背景吸收校正background correction|背景校正background gactor|背景因子background genotype|背景基因型[与所研究的表型直接相关的基因以外的全部基因]background hybridization|背景杂交background radiation|背景辐射，本底辐射backmixing|反向混合backside attack|背面进攻backward reaction|逆向反应backwashing|反洗bacmid|杆粒[带有杆状病毒基因组的质粒，可在细菌和昆虫细胞之间穿梭]bacteremia|菌血症bacteria|（复）细菌bacteria rhodopsin|细菌视紫红质bacterial adhesion|细菌粘附bacterial alkaline phosphatase|细菌碱性磷酸酶bacterial artificial chromosome|细菌人工染色体bacterial colony|（细菌）菌落bacterial colony counter|菌落计数器bacterial conjugation|细菌接合bacterial filter|滤菌器bacterial invasion|细菌浸染bacterial motility|细菌运动性bacterial rgodopsin|细菌视紫红质，细菌紫膜质bacterial vaccine|菌苗bacterial virulence|细菌毒力bactericidal reaction|杀（细）菌反应bactericide|杀（细）菌剂bactericidin|杀（细）菌素bactericin|杀（细）菌素bacteriochlorophyll|细菌叶绿素bacteriochlorophyll protein|细菌叶绿素蛋白bacteriocide|杀（细）菌剂bacteriocin|细菌素bacteriocin typing|细菌素分型[利用细菌素对细胞进行分型]bacterioerythrin|菌红素bacteriofluorescein|细菌荧光素bacteriology|细菌学bacteriolysin|溶菌素bacteriolysis|溶菌（作用）bacteriolytic reaction|溶菌反应bacteriophaeophytin|细菌叶褐素bacteriophage|噬菌体bacteriophage arm|噬菌体臂bacteriophage conversion|噬菌体转变bacteriophage head|噬菌体头部bacteriophage surface expression system|噬菌体表面表达系统bacteriophage tail|噬菌体尾部bacteriophage typing|噬菌体分型bacteriophagology|噬菌体学bacteriopurpurin|菌紫素bacteriorhodopsin|细菌视紫红质bacteriosome|细菌小体[昆虫体内一种含有细菌的结构]bacteriostasis|抑菌(作用)bacteriostat|抑菌剂bacteriotoxin|细菌毒素bacteriotropin|亲菌素bacterium|细菌bacteroid|类菌体baculovirus|杆状病毒bag sealer|封边机baking soda|小苏打BAL 31 nuclease|BAL 31核酸酶balance|天平balanced heterokaryon|平衡异核体balanced lethal|平衡致死balanced lethal gene|平衡致死基因balanced linkage|平衡连锁balanced pathogenicity|平衡致病性balanced polymorphism|平衡多态性balanced salt solution|平衡盐溶液balanced solution|平衡溶液balanced translocation|平衡易位balbaini ring|巴尔比亚尼环[由于RNA大量合成而显示特别膨大的胀泡，在多线染色体中形成独特的环]Balbiani chromosome|巴尔比亚尼染色体[具有染色带的多线染色体，1881年首先发现于双翅目摇蚊幼虫]ball mill|球磨ball mill pulverizer|球磨粉碎机ball milling|球磨研磨balloon catheter|气囊导管[可用于基因送递，如将DNA导入血管壁]banana bond|香蕉键band|条带，带[见于电泳、离心等]band broadening|条带加宽band sharpening|条带变细，条带锐化band width|带宽banding pattern|带型banding technique|显带技术,分带技术barbiturate|巴比妥酸盐barium|钡barly strip mosaic virus|大麦条纹花叶病毒barly yellow dwarf virus|大麦黄矮病毒barnase|芽胞杆菌RNA酶[见于解淀粉芽胞杆菌]barophilic baceria|嗜压菌baroreceptor|压力感受器barotaxis|趋压性barotropism|向压性barr body|巴氏小体barrel|桶，圆筒[可用于描述蛋白质立体结构，如beta折叠桶]barrier|屏障，垒barstar|芽胞杆菌RNA酶抑制剂[见于解淀粉芽胞杆菌]basal|基础的，基本的basal body|基粒basal body temperature|基础体温basal component|基本成分，基本组分basal expression|基础表达，基态表达basal granule|基粒basal heat producing rate|基础产热率basal lamina|基膜，基板basal level|基础水平，基态水平basal medium|基本培养基，基础培养基basal medium Eagle|Eagle基本培养基basal metabolic rate|基础代谢率basal metabolism|基础代谢basal promoter element|启动子基本元件basal transcription|基础转录，基态转录basal transcription factor|基础转录因子base|碱基；碱base analog|碱基类似物，类碱基base catalysis|碱基催化base composition|碱基组成base pairing|碱基配对base pairing rules|碱基配对法则,碱基配对规则base peak|基峰base pire|碱基对base ratio|碱基比base stacking|碱基堆积base substitution|碱基置换baseline|基线baseline drift|基线漂移baseline noise|基线噪声basement membrane|基底膜basement membrane link protein|基底膜连接蛋白basic amino acid|碱性氨基酸basic fibroblast growth factor|碱性成纤维细胞生长因子basic fuchsin|碱性品红basic medium|基础培养基basic number of chromosome|染色体基数basic protein|碱性蛋白质basic solvent|碱性溶剂basic taste sensation|基本味觉basidiocarp|担子果basidiomycetes|担子菌basidium|担子basipetal translocation|向基运输basket centrifuge|（吊）篮式离心机basket drier|篮式干燥机basket type evaporator|篮式蒸发器basonuclin|碱（性）核蛋白[见于角质形成细胞，含有多对锌指结构] basophil|嗜碱性细胞basophil degranulation|嗜碱性细胞脱粒basophilia|嗜碱性batch|分批；批，一批batch cultivation|分批培养batch culture|分批培养物batch digestor|分批消化器batch extraction|分批抽提，分批提取batch fermentation|分批发酵，（罐）批发酵batch filtration|分批过滤batch operation|分批操作batch process|分批工艺，分批法batch reactor|间歇反应器，分批反应器batch recycle cultivation|分批再循环培养batch recycle culture|分批再循环培养（物）bathochrome|向红基bathochromic shift|红移bathorhodopsin|红光视紫红质，前光视紫红质batrachotoxin|树蛙毒素[固醇类生物碱，作用于钠通道] baytex|倍硫磷BCG vaccine|卡介苗bead mill|玻珠研磨机bead mill homogenizer|玻珠研磨匀浆机bean sprouts medium|豆芽汁培养基beauvericin|白僵菌素becquerel|贝可（勒尔）bed volume|（柱）床体积bee venom|蜂毒beef broth|牛肉汁beef extract|牛肉膏，牛肉提取物beet yellows virus|甜菜黄化病毒Beggiatoa|贝日阿托菌属[属于硫细菌]behavior|行为；性质，性能behavioral control|行为控制behavioral isolation|行为隔离behavioral thermoregulation|行为性体温调节behenic acid|山yu酸，二十二（烷）酸belt desmosome|带状桥粒belt press|压带机belt press filter|压带（式）滤器bench scale|桌面规模，小试规模benchtop bioprocessing|桌面生物工艺[小试规模]benchtop microcentrifuge|台式微量离心机bend|弯曲；弯管；转折bending|弯曲；转折，回折beneficial element|有益元素bent bond|弯键bent DNA|弯曲DNA,转折DNAbenzene|苯benzhydrylamine resin|二苯甲基胺树脂benzidine|联苯胺benzilate|三苯乙醇酸（或盐或酯）benzimidazole|苯并咪唑benzodiazine|苯并二嗪，酞嗪benzoin|苯偶姻，安息香benzophenanthrene|苯并菲benzopyrene|苯并芘benzoyl|苯甲酰基benzoylglycine|苯甲酰甘氨酸benzyl|苄基benzyladenine|苄基腺嘌呤benzylaminopurine|苄基氨基嘌呤benzylisoquinoline|苄基异喹啉benzylisoquinoline alkaloid|苄基异喹啉（类）生物碱benzylpenicillin|苄基青霉素berberine|小檗碱Bertrand rule|贝特朗法则bestatin|苯丁抑制素[可抑制亮氨酸氨肽酶的一种亮氨酸类似物]C value|C值[单倍基因组DNA的量]C value paradox|C值悖理[物种的C值和它的进化复杂性之间无严格对应关系]C4 dicarboxylic acid cycle|C4二羧酸循环cachectin|恶液质素[即alfa肿瘤坏死因子]cadaverine|尸胺cadherin|钙粘着蛋白[介导依赖（于）钙的细胞间粘着作用的一类跨膜蛋白质，分为E-,N-,P-等若干种，E表示上皮（epithelia)，N表示神经（neural），P表示胎盘（placental）] cadmium|镉caerulin|雨蛙肽cage|笼cage compound|笼形化合物cage coordination compound|笼形配合物cage effect|笼效应cage structure|笼形结构[非极性分子周围的水分子所形成的有序结构]calbindin|钙结合蛋白calciferol|麦角钙化（固）醇calcimedin|钙介蛋白[钙调蛋白拮抗剂]calcineurin|钙调磷酸酶[依赖于钙调蛋白的丝氨酸—苏氨酸磷酸酶]calcionin|降钙素calcium binding protein|钙结合蛋白（质）calcium binding site|钙结合部位calcium channel|钙通道calcium chloride|氯化钙calcium influx|钙流入calcium mediatory protein|钙中介蛋白（质）calcium phosphate|磷酸钙calcium phosphate precipitation|磷酸盐沉淀calcium pump|钙泵calcium sensor protein|钙传感蛋白（质）calcium sequestration|集钙（作用）calcyclin|钙（细胞）周边蛋白calcyphosine|钙磷蛋白[是依赖于cAMP的蛋白激酶的磷酸化底物]caldesmon|钙调（蛋白）结合蛋白[主要见于平滑肌，可与钙调蛋白及肌动蛋白结合] calelectrin|钙电蛋白[最初发现于鳗鱼电器官的一种钙结合蛋白]calf intestinal alkaline phosphatase|（小）牛小肠碱性磷酸酶calf serum|小牛血清calf thymus|小牛胸腺calgranulin|钙粒蛋白calibration|校准，标准calibration curve|校正曲线calibration filter|校准滤光片calibration protein|校准蛋白calicheamycin|刺孢霉素[来自刺孢小单胞菌的抗肿瘤抗生素，带有二炔烯官能团] calicivirus|杯状病毒calli|（复）胼胝体，愈伤组织[用于植物]；胼胝[见于动物皮肤]callose|胼胝质，愈伤葡聚糖callose synthetase|愈伤葡聚糖合成酶callus|胼胝体，愈伤组织[用于植物]；胼胝[见于动物皮肤]callus culture|愈伤组织培养calmodulin|钙调蛋白calnexin|钙联结蛋白[内质网的一种磷酸化的钙结合蛋白]calomel|甘汞calomel electrode|甘汞电极calorie|卡calpactin|依钙（结合）蛋白[全称为“依赖于钙的磷脂及肌动蛋白结合蛋白”]calpain|（需）钙蛋白酶calpain inhibitor|（需）钙蛋白酶抑制剂calpastatin|(需）钙蛋白酶抑制蛋白calphobindin|钙磷脂结合蛋白calphotin|钙感光蛋白[感光细胞的一种钙结合蛋白]calprotectin|（肌）钙网蛋白[骨骼肌肌质网膜上的钙结合蛋白]calretinin|钙（视）网膜蛋白calsequestrin|（肌）集钙蛋白calspectin|钙影蛋白calspermin|钙精蛋白[睾丸的一种钙调蛋白结合蛋白]caltractin|钙牵蛋白[一种与基粒相关的钙结合蛋白]Calvin cycle|卡尔文循环，光合碳还原环calyculin|花萼海绵诱癌素[取自花萼盘皮海绵的磷酸酶抑制剂]calyptra|根冠calyx|花萼cambium|形成层[见于植物]cAMP binding protein|cAMP结合蛋白cAMP receptor protein|cAMP受体蛋白cAMP response element|cAMP效应元件cAMP response element binding protein|cAMP效应元件结合蛋白Campbell model|坎贝尔模型camphane|莰烷camphane derivative|莰烷衍生物camphore|樟脑camptothecin|喜树碱Campylobacter|弯曲菌属Campylobacter fetus|胎儿弯曲菌属Canada balsam|加拿大香脂，枞香脂canaline|副刀豆氨酸canalization|[表型]限渠道化，发育稳态[尽管有遗传因素和环境条件的干扰，表型仍保持正常]canavanine|刀豆氨酸cancer|癌症cancer metastasis|癌症转移cancer suppressor gene|抑癌基因cancer suppressor protein|抑癌基因产物，抑癌蛋白（质）candicidin|杀假丝菌素candida|念珠菌属Candida albicans|白色念珠菌candle jar|烛罐cannabin|大麻苷；大麻碱canonical base|规范碱基canonical molecular orbital|正则分子轨道canonical partition function|正则配分函数canonical sequence|规范序列cantharidin|斑蝥素canthaxanthin|角黄素canyon|峡谷[常用于比喻某些生物大分子的主体结构特征]cap|帽，帽（结构）cap binding protein|帽结合蛋白cap site|加帽位点capacitation|获能[特指镜子在雌性生殖道中停留后获得使卵子受精的能力]capacity|容量capacity factor|容量因子capillarity|毛细现象capillary|毛细管；毛细血管capillary absorption|毛细吸收capillary action|毛细管作用capillary attraction|毛细吸力capillary column|毛细管柱capillary culture|毛细管培养capillary electrode|毛细管电极capillary electrophoresis|毛细管电泳capillary free electrophoresis|毛细管自由流动电泳capillary gas chromatography|毛细管气相层析capillary isoelectric focusing|毛细管等电聚焦capillary isotachophoresis|毛细管等速电泳capillary membrane module|毛细管膜包capillary transfer|毛细管转移[通过毛细管作用进行核酸的印迹转移] capillary tube|毛细管capillary tubing|毛细管capillary zone electrophoresis|毛细管区带电泳capillovirus|毛状病毒组capping|加帽，加帽反应；封闭反应；帽化，成帽capping enzyme|加帽酶capping protein|[肌动蛋白]加帽蛋白caprin|癸酸甘油酯caproin|己酸甘油酯capromycin|卷曲霉素，缠霉素caproyl|己酸基caprylin|辛酸甘油酯capsid|（病毒）衣壳，（病毒）壳体capsid protein|衣壳蛋白capsidation|衣壳化capsomer|（病毒）壳粒capsular polysaccharide|荚膜多糖capsulation|包囊化（作用），胶囊化（作用）capsule|荚膜capsule swelling reaction|荚膜肿胀反应capture|捕捉，俘获capture antigen|捕捉抗原[酶免疫测定中用于捕捉抗体的抗原]capture assay|捕捉试验carbamyl|氨甲酰基carbamyl ornithine|氨甲酰鸟氨酸carbamyl phosphate|氨甲酰磷酸carbamyl phosphate synthetase|氨甲酰磷酸合成酶carbamyl transferase|氨甲酰（基）转移酶carbamylation|氨甲酰化carbanion|碳负离子carbanyl group|羰基carbene|卡宾carbenicillin|羧苄青霉素carbenoid|卡宾体carbocation|碳正离子carbodiimide|碳二亚胺carbohydrate|糖类，碳水化合物carbohydrate fingerprinting|糖指纹分析carbohydrate mapping|糖作图，糖定位carbohydrate sequencing|糖测序carbol fuchsin|石炭酸品红carboline|咔啉，二氮芴carbon assimilation|碳同化carbon balance|碳平衡carbon cycling|碳循环carbon dioxide|二氧化碳carbon dioxide compensation|二氧化碳补偿点carbon dioxide fertilization|二氧化碳施肥carbon dioxide fixation|二氧化碳固定carbon dioxide tension|二氧化碳张力carbon fiber|碳纤维carbon fixation|碳固定carbon isotope|碳同位素carbon isotope analysis|碳同位素分析carbon isotope composition|碳同位素组成carbon monoxide|一氧化碳carbon source|碳源carbonate|碳酸盐，碳酸酯carbonate plant|碳化植物carbonic anhydrase|碳酸酐酶carbonium ion|碳正离子carbonyl|羰基carbonylation|羰基化carboxydismutase|羰基岐化酶，核酮糖二磷酸羧化酶 carboxydotrophic bacteria|一氧化碳营养菌carboxyglutamic acid|羧基谷氨酸carboxyl|羧基carboxyl protease|羧基蛋白酶carboxyl terminal|羧基端carboxyl transferase|羧基转移酶carboxylase|羧化酶carboxylation|羧（基）化carboxylic acid|羧酶carboxymethyl|羧甲基carboxymethyl cellulose|羧甲基纤维素carboxypeptidase|羧肽酶[包括羧肽酶A、B、N等]carcinogen|致癌剂carcinogenesis|致癌，癌的发生carcinogenicity|致癌性carcinoma|癌carcinostatin|制癌菌素cardenolide|强心苷cardiac aglycone|强心苷配基，强心苷元cardiac cycle|心动周期cardiac glycoside|强心苷cardiac receptor|心脏感受器cardiohepatid toxin|心肝毒素[如来自链球菌]cardiolipin|心磷脂cardiotoxin|心脏毒素cardiovascular center|心血管中枢cardiovascular disease|心血管疾病cardiovirus|心病毒属[模式成员是脑心肌炎病毒]carlavirus|香石竹潜病毒组carmine|洋红carminomycin|洋红霉素carmovirus|香石竹斑驳病毒组carnation latent virus|香石竹潜病毒carnation mottle virus|香石竹斑驳病毒carnation ringspot virus|香石竹环斑病毒carnitine|肉碱carnitine acyl transferase|肉碱脂酰转移酶carnosine|肌肽[即beta丙氨酰组氨酸]carotene|胡萝卜素carotene dioxygenase|胡萝卜素双加氧酶carotenoid|类胡萝卜素carotenoprotein|胡萝卜素蛋白carpel|[植物]心皮carrageen|角叉菜，鹿角菜carrageenin|角叉菜胶carrier|载体，运载体，携载体；携带者，带（病）毒者，带菌者 carrier ampholyte|载体两性电解质carrier catalysis|载体催化carrier coprecipitation|载体共沉淀carrier DNA|载体DNAcarrier free|无载体的carrier phage|载体噬菌体carrier precipitation|载体沉淀（作用）carrier state|携带状态carriomycin|腐霉素，开乐霉素cartridge|[萃取柱的]柱体；软片，胶卷；子弹，弹药筒casamino acid|（水解）酪蛋白氨基酸，酪蛋白水解物cascade|串联，级联，级联系统cascade amplification|级联放大cascade chromatography|级联层析cascade fermentation|级联发酵casein|酪蛋白，酪素casein kinase|酪蛋白激酶[分I、II两种]Casparian band|凯氏带[见于植物内表皮细胞]Casparian strip|凯氏带cassette|盒，弹夹[借指DNA序列组件]cassette mutagenesis|盒式诱变casting|铸，灌制CAT box|CAT框[真核生物结构基因上游的顺式作用元件]catabolism|分解代谢catabolite gene activator protein|分解代谢物基因激活蛋白 catabolite repression|分解代谢物阻抑，分解代谢产物阻遏catalase|过氧化氢酶catalytic active site|催化活性位catalytic activity|催化活性catalytic antibody|催化性抗体，具有催化活性的抗体catalytic constant|催化常数[符号Kcat]catalytic core|催化核心catalytic mechanism|催化机理catalytic RNA|催化性RNAcatalytic selectivity|催化选择性catalytic site|催化部位catalytic subunit|催化亚基cataphoresis|阳离子电泳cataract|白内障catechin|儿茶素catechol|儿茶酚，邻苯二酚catecholamine|儿茶酚胺catecholamine hormones|儿茶酚胺类激素catecholaminergic recptor|儿茶酚胺能受体catenane|连环（体），连锁，链条[如DNA连环体]；索烃catenating|连环，连接catenation|连环，连锁，成链catenin|连环蛋白[一类细胞骨架蛋白，分alfa/beta/gama三种] catharanthus alkaloid|长春花属生物碱cathepsin|组织蛋白酶[分为A、B、C、D、E…H、L等多种]catheter|导管cathode layer enrichment method|阴极区富集法cathode ray polarograph|阴极射线极谱仪cation acid|阳离子酸cationic acid|阳离子酸cationic catalyst|正离子催化剂cationic detergent|阳离子（型）去污剂cationic initiator|正离子引发剂cationic polymerization|正离子聚合，阳离子聚合 cationic surfactant|阳离子（型）表面活性剂cationization|阳离子化cauliflower mosaic virus|花椰菜花叶病毒caulimovirus|花椰菜花叶病毒组caulobacteria|柄病毒Cavendish laboratory|（英国）卡文迪什实验室caveola|小窝，小凹caveolae|(复）小窝，小凹caveolin|小窝蛋白cavitation|空腔化（作用）cavity|沟槽，模槽，空腔dammarane|达玛烷dammarane type|达玛烷型Dane particle|丹氏粒[乙型肝炎病毒的完整毒粒]dansyl|丹（磺）酰，1-二甲氨基萘-5-磺酰dansyl chloride|丹磺酰氯dansyl method|丹磺酰法dantrolene|硝苯呋海因[肌肉松弛剂]dark current|暗电流dark field|暗视野，暗视场dark field microscope|暗视野显微镜，暗视场显微镜 dark field microscopy|暗视野显微术，暗视场显微术 dark reaction|暗反应dark repair|暗修复dark respiration|暗呼吸dark room|暗室，暗房dark seed|需暗种子data accumulation|数据积累data acquisition|数据获取data analysis|数据分析data bank|数据库data base|数据库data handling|数据处理data logger|数据记录器data logging|数据记录data output|数据输出data processing|数据处理data recording|数据记录dauermodification|持续饰变daughter cell|子代细胞daughter chromatid|子染色单体daughter chromosome|子染色体daughter colony|子菌落[由原生菌落续发生长的小菌落]daunomycin|道诺霉素daunorubicin|道诺红菌素de novo sequencing|从头测序de novo synthesis|从头合成deactivation|去活化（作用），失活（作用），钝化deacylated tRNA|脱酰tRNAdead time|死时间dead volume|死体积deadenylation|脱腺苷化DEAE Sephacel|[商]DEAE-葡聚糖纤维素，二乙氨乙基葡聚糖纤维素 dealkylation|脱烷基化deaminase|脱氨酶deamination|脱氨（基）death phase|死亡期[如见于细胞生长曲线]death point|死点deblocking|去封闭debranching enzyme|脱支酶，支链淀粉酶debris|碎片，残渣decahedron|十面体decane|癸烷decantation|倾析decanting|倾析decapacitation|去（获）能decarboxylase|脱羧酶decarboxylation|脱羧（作用）decay|原因不明腐败decay accelerating factor|衰变加速因子decay constant|衰变常数deceleration phase|减速期[如见于细胞生长曲线]dechlorination|脱氯作用deciduous leaf|落叶decline phase|[细胞生长曲线的]衰亡期decoagulant|抗凝剂decoding|译码，解码decomposer|分解者[可指具有分解动植物残体或其排泄物能力的微生物] decompression|降压，减压decondensation|解凝（聚）decontaminant|净化剂，去污剂decontaminating agent|净化剂，去污剂decontamination|净化，去污decorin|核心蛋白聚糖[一种基质蛋白聚糖，又称为PG-40]dedifferentiation|去分化，脱分化deep colony|深层菌落deep etching|深度蚀刻deep jet fermentor|深部喷注发酵罐deep refrigeration|深度冷冻deep shaft system|深井系统[如用于污水处理]defasciculation factor|解束因子[取自水蛭，可破坏神经束]defective|缺损的，缺陷的defective interfering|缺损干扰defective interfering particle|缺损干扰颗粒，干扰缺损颗粒defective interfering RNA|缺损干扰RNAdefective interfering virus|缺损干扰病毒defective mutant|缺损突变体，缺陷突变型，缺陷突变株defective phage|缺损噬菌体，缺陷噬菌体defective virus|缺损病毒，缺陷病毒defense|防御，防卫defense peptide|防卫肽defense response|防御反应，防卫反应defensin|防卫素[动物细胞的内源性抗菌肽]deficiency|缺乏，缺损，缺陷deficient|缺少的，缺损的，缺陷的defined|确定的defined medium|确定成分培养基，已知成分培养液defintion|定义defoliating agent|脱叶剂defoliation|脱叶deformylase|去甲酰酶[见于原核细胞，作用于甲酰甲硫氨酸]degasser|脱气装置degassing|脱气，除气degeneracy|简并；简并性，简并度degenerate|简并的degenerate codon|简并密码子degenerate oligonucleotide|简并寡核苷酸degenerate primer|简并引物degenerate sequence|简并序列degeneration|退化，变性degenerin|退化蛋白[与某些感觉神经元的退化有关]deglycosylation|去糖基化degradable polymer|降解性高分子degradation|降解degranulation|脱（颗）粒（作用）degree of acidity|酸度degree of dominance|显性度degree of polymerization|聚合度degron|降解决定子[决定某一蛋白发生降解或部分降解的序列要素] deguelin|鱼藤素dehalogenation|脱卤（作用）dehardening|解除锻炼dehumidifier|除湿器dehydratase|脱水酶dehydrated medium|干燥培养基dehydration|脱水（作用）dehydroepiandrosterone|脱氢表雄酮dehydrogenase|脱氢酶dehydrogenation|脱氢（作用）dehydroluciferin|脱氢萤光素deionization|去离子（作用）deionized|去离子的deionized water|去离子水deionizing|去离子（处理）delayed early transcription|（延）迟早期转录[可特指病毒]delayed fluorescence|延迟荧光delayed heat|延迟热delayed hypersensitivity|延迟（型）超敏反应delayed ingeritance|延迟遗传delayed type hypersensitivity|迟发型超敏反应deletant|缺失体deletion|缺失deletion mapping|缺失定位，缺失作图deletion mutagenesis|缺失诱变deletion mutant|缺失突变体deletion mutantion|缺失突变deletional recombination|缺失重组delignification|脱木质化（作用）deliquescence|潮解delivery flask|分液瓶delocalized bond|离域键。
抗体公司
赛信通（上海）生物试剂有限公司
上海市浦东南路1101号远东大厦514室，200120 info@cst www.cst 2158356288 公司总部: 美国
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privatelyowned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activationstate and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine. 总引用数为4670，来自于1966篇文章。最常引用的试剂包括： Akt, ERK2, ERK1, p38, Akt1。
AbD Serotec (BioRad)
蛋白酶抑制剂Cocktail使用说明书奥默生物
奥默生物电话：021-5096 7598 邮箱：techsupport@ 网站：产品简介：本产品是由6种独立的蛋白酶抑制剂（不含EDTA）按照优化的配比配置而成的蛋白酶抑制剂混合物。
其作用的靶点分别为丝氨酸蛋白酶，丝氨酸半胱氨酸蛋白酶，氨肽酶，半胱氨酸蛋白酶和天冬氨酸蛋白酶等，广泛作用于各种蛋白酶，可称之为广谱蛋白酶抑制剂。
本产品应于-20℃环境下密封保存，产品有效期为2年。
使用时可短时间放置于常温或4℃中，用毕应立即放回-20℃中保存。
储存条件：蛋白酶抑制剂Cocktail (不含EDTA，100X DMSO储液)蛋白酶抑制剂Cocktail 使用说明书蛋白酶抑制剂通过抑制蛋白酶的活性，减少蛋白酶对蛋白的分解，从而有效地提高蛋白质得出率，而且不使细胞及组织本身的性质发生改变。
作用原理：产品组成：成分MTT法CCK法 AEBSFAprotininBestatinE-64LeupeptinPepstatin A Cysteine proteases Serine proteases Aminopeptidases Serine proteases Serine and cysteine proteases Aspartic proteases Irreversible Reversible Reversible ReversibleReversible Irreversible 靶点靶点类型运输条件： 蓝冰运输。
奥默生物使用说明：1. 本产品适用于哺乳动物细胞及组织的蛋白质提取及纯化，蛋白免疫印迹（WesternBlot）,免疫共沉淀（Co-IP），免疫荧光（IF），免疫组织化学（IHC），激酶测定（kinaseassay）和抗体，酶诊断试剂盒（Dignose Kit）等。
2. 实验时，按照1:100的容积比，将Cocktail预先加入在已准备好的实验体系中，轻轻混合均匀。
注意事项：1. 本产品不含EDTA，为100×DMSO储存液形式。
安捷伦产品目录
15
Real-Time PCR
16
Mx3000P QPCR System
17
Brilliant III Ultra-Fast SYBR Green QPCR and QRT-PCR Reagents
18
Brilliant III Ultra-Fast QPCR and QRT-PCR Reagents
Agilent / STRATAGENE
Agilent website: /genomics
Welgene | Agilent Stratagene
威健股份有限公司 | Stratagene 總代理
Table of Content
Table of Contents
/ XL1-Red Competent Cells SoloPack Gold Supercompetent Cells
/ TK Competent Cells Specialty Cells
/ Classic Cells / Fine Chemicals For Competent Cells
適用於 UNG 去汙染或 bisulphite
sequencing
適用於 TA Cloning
最高敏感性
取代傳統 Taq 的好選擇
-
2
威健股份有限公司 | Stratagene 總代理
PCR Enzyme & Instrument
Agilent SureCycler 8800
市場上領先的 cycling 速度和 sample 體積 10 ～ 100 μL 簡易快速可以選擇 96 well 和 384 well 操作盤 優秀的溫控設備讓各個 well 都能保持溫度的穩定 七吋的高解析度觸控螢幕讓操作上更為簡便 可以透過網路遠端操控儀器及監控儀器 Agilent 專業的技術支援可以幫助您應對各種 PCR 的問題
双靶标实时荧光PCR检测技术用于牛结核病快速诊断的研究
#$%1/#
+Y+7:? VC+!:7:;?#,:! 9Y T;:TC;#,RC,! !:7:<7#,R 9">#,:A8,R7#++8:+<",7C#,#,R !#UU:;:,7<",<:,7;C7#",+"U CJ+)5/+,&%0*I5)L01+8+T:,+#",+&\+#,RF=6"U)$<"??",+7C,!C;!,",789:;<8A"8+?Y<"9C<7:;#C%=WD&+7;C#,+ C+C?TA#U#<C7#", 7:?TAC7:$74: +T:<#U#<#7Y "U !8CA-7C;R:7;:CA-7#?:UA8";:+<:,7 _3S !:7:<7#", "U DWX3 VC+ !:7:;?#,:!&DZKW'.%A#b8#!<8A78;:$eT:;7DWX"SKM %eT:;7&$eT:;7DWX"SKM\A7;C%eT:;7\A7;C&C,!!8CA-
)2$34)%*1*W89:;<8A"+#+$9">#,:'6,#?CA!#+:C+:+'D"A:<8AC;T;"9:7:<4,#b8:+'F#CR,"+#+ )56"*&%)7%'8*=C7#",CAE:YS:+:C;<4C,!F:>:A"T?:,7_;"R;C? %)%))LM3)/%1)%0&'E:YS:+:C;<4C,! F:>:A"T?:,7_AC,"UW#9:7687","?"8+S:R#",%ed)%))%$dL%%%2=-%$&
抗D说明书
生产厂家：英国Millipore (UK)Limited中国大陆地区总代理上海博力医学生物科贸有限公司产品简介：抗D（IgM+IgG）血型定型试剂直接凝集法可识别D，弱D和不完全D间接抗人球蛋白实验可识别DVI。
效价达1：256，IgM克隆号Th-28，IgG克隆号MS-26，该产品已通过微米的过滤膜过滤，并在胰蛋白酶大豆琼脂中培养3至6天和在沙氏葡萄糖琼脂中培养5至7天后通过一个生物负荷测试<1个细菌群落每毫升（CFU/ml）HIV、HCV、HBsAg、EBV、MAP病毒检测阴性，有效期3年。
注册证号：国食药监械（进）字2010第3403117号使用此产品的临床意义：抗D （IgM）不与DVI细胞反应，不能检测DVI （弱D）；抗D （IgM+IgG）中的IgG能与DVI 细胞反应，能检测DVI （弱D）。
该产品应用于玻片法、室温盐水试管法、微孔板法和间接抗人球蛋白法检测人红细胞中的D抗原。
产品的预期应用项目和使用量：Rh 血型定型试剂；检验方法：玻片法、室温盐水试管法、间接抗人球蛋白实验（用于弱D样本的检测）、微孔板法；使用量：根据实验室实验方法的不同而定。
详细请看下面：？抗D（IgM+IgG）血型定型试剂（单克隆抗体）操作规程【产品名称】通用名称：抗D（IgM+IgG）血型定型试剂（单克隆抗体）英文名称：Anti-D Blood Grouping Reagent (Monoclonal Human IgM/IgG Blend)【包装规格】10mL/瓶，10瓶/盒。
【预期用途】该产品应用于玻片法、室温盐水试管法、微孔板法和间接抗人球蛋白法检测人红细胞中的D抗原。
红细胞RhD亚型系统最早是由Levine和Stetson在1939年提出来的。
RhD阴性的人在接受RhD阳性血液输血或者孕有RhD阳性的胎儿时，会产生抗-D抗体，从而导致严重的新生儿溶血症或输血性溶血反应。
“弱D型”通常用来表述RhD抗原数目偏少的红细胞；“部分D型”通常用来表述缺乏部分RhD抗原表位的红细胞；“D VI”属于“部分D型”的范畴。
蛋白核酸样品制备-bio-rad产品介绍
Quantum Prep质粒中型制备试剂盒采用了简便的离心柱操作流程，显著地缩短了大量质粒DNA制备所需的时间，所制备的DNA可用于转染、亚克隆和其它酶处理。
Chelex树脂
Bio-Rad提供两种以Chelex为基质的树脂，用于从多种粗样品(如血液、细菌、组织和头发)中抽提DNA。由于所抽提的DNA通常用于下游的PCR，因此它必须不含能抑制扩增反应的金属离子，Chelex由成对的亚氨基二乙酸离子结合在苯乙烯二乙烯苯基质上形成，对多价阳离子具有很强的选择性，从而有效地去除这类污染杂质。
■■哺乳动物、植物、酵母、微生物样品的细胞裂解和蛋白抽提实验方法
■■该试剂盒能使用于任何特殊种类的蛋白提取，不仅局限于下游MicroRotofor等电聚焦
■■试剂盒抽提的蛋白样品结果，不必再改变缓冲液条件，而能迅速使用MicroRotofor进行等电聚焦实验。
ReadyPrep小研磨试剂盒
Readyprep mini grinders研磨处理小量生物样品，对于核酸和蛋白质具有极高的回收率，每个小研磨棒( minigrinders )包括1.5ml含研磨树脂的研磨管和相应的研磨杵，研磨树脂是一种中性强张力的微粒状研磨剂，不与蛋白质和核酸结合。Readyprep mini grinders是一次性使用的试剂盒，并且不含有核酸酶或蛋白酶，他们也是MicroRotofor裂解试剂盒(哺乳动物)的组成成分，可以分开单独出售，每20个为一个包装，mini grinders具有以下特性：
Aurum质粒小型制备试剂盒能为ቤተ መጻሕፍቲ ባይዱ下领域的研究制备高产量重现性高的质粒DNA：
■■全自动荧光测序
■■限制性酶切
■■连接和转化
■■转染
欧盟对草莓中的农残限量要求
0,02*
0,02*
0,02* 0,05*
Cypermethrin (cypermethrin including other mixtures of constituent isomers (sum of isomers)) (F) Cyproconazole (F) Cyprodinil (F) (R) Cyromazine Dalapon Daminozide (sum of daminozide and 1,1-dimethyl-hydrazine, expressed as daminozide) Dazomet (Methylisothiocyanate resulting from the use of dazomet and metam) DDT (sum of p,p´-DDT, o,p´-DDT, p-p´-DDE and p,p´-TDE (DDD) expressed as DDT) (F) Deltamethrin (cis-deltamethrin) (F) Desmedipham Diallate Diazinon (F) Dicamba Dichlobenil Dichlorprop: sum of dichlorprop (including dichlorprop-P) and its conjugates, expressed as dichlorprop Dichlorvos
1 0,01* 0,05* 0,01* 0,02 0,01* 0,01* 0,02* 0,1* 0,05* 0,02* 0,05
5 0,05* 0,05* 0,05* 0,2 0,5 0,05* 0,01* 0,01* 0,05* 0,01* 0,05*
0,5
0,02* 2
血培养奥默柯达酵母鉴定方法学比较及药物敏感性
ZHOU Menglan, YU Shuying, XIAO Meng, XU Yingchun. （Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing 100730, China）
and protein extraction method, respectively. Only 20 (58.8%) isolates were initially correctly identified as K. ohmeri by local
21）；北京市科技计划首都健康保障培育研究项目 （Z181100001618015）；“十三五”国家科技重大专 项“（2018ZX10712001）。 作者单位：1. 中国医学科学院北京协和医院检验科，侵袭性真菌
hospitals were reviewed. Standard broth microdilution (BMD) method was used to determine the in vitro antifungal susceptibility.
Results Accurate species identification was achieved in 94.1% and 100% of the cases by VITEK 2-Compact and VITEK MS,
乌司奴单抗注射液-详细说明书与重点
本品仅用于皮下给药。
如需静脉输注时，请使用静脉制剂。
乌司奴单抗注射液【商品名称】喜达诺®。
【英文名称】Ustekinumab Injection。
【汉语拼音】Wusinu Dankang Zhusheye。
【成份】主要成份：乌司奴单抗，辅料：蔗糖、L-组氨酸、L-组氨酸盐酸盐一水合物、聚山梨酯80、注射用水。
【性状】应为无色至淡黄色液体。
【适应症】斑块状银屑病：本品适用于对环孢素、甲氨喋呤（MTX）等其他系统性治疗或PUVA （补骨脂素和紫外线A）不应答、有禁忌或无法耐受的成年中重度斑块状银屑病患者。
克罗恩病：本品适用于对传统治疗或肿瘤坏死因子α（TNFα）拮抗剂应答不足、失应答或无法耐受的成年中重度活动性克罗恩病患者。
【规格】45mg/0.5ml/支；90mg/1.0ml/支。
【用法用量】本品仅用于皮下给药。
如需静脉输注时，请使用静脉制剂。
本品应在医生的指导及监督下使用，医生应具备本品适应症的诊断及治疗经验。
斑块状银屑病：本品推荐剂量为首次45 mg皮下注射，4周后及之后每12周给予一次相同剂量。
治疗28周仍未应答的患者应考虑停止用药。
克罗恩病：本品推荐剂量为首次根据体重确定的单次静脉输注（IV）分层剂量（表1），8周后90mg皮下注射，此后建议每12周皮下注射90mg。
表1本品首次静脉内给药推荐剂量a：约为6 mg/kg。
首次皮下注射8周后应答不足的患者可在此时接受第二剂皮下注射。
如果患者在每12周给药1次期间失去应答，可将给药频率增加至每8周1次，这可能对患者有益。
之后患者可以每8周或每12周给药1次，具体由临床状况决定。
第16周时或在调整至每8周给药1次后16周，如果患者仍然没有治疗获益的证据，应考虑停止治疗。
本品治疗期间可继续使用免疫调节剂和/或糖皮质激素。
对本品有应答的患者可依据标准治疗减量或停止糖皮质激素治疗。
如果治疗中断，重新开始治疗时采用每8周1次皮下注射方案是安全有效的。